Matches in Nanopublications for { ?s ?p "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP844678.RACh5dTaqGXjpKpVAfY7FbsTOIF2Q5qbwim6Mm3OrzQA4130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844678.RACh5dTaqGXjpKpVAfY7FbsTOIF2Q5qbwim6Mm3OrzQA4130_provenance.
- NP561545.RAOfrHxfbuny3HTSWQxOlfKvmyt223zdKr2MWZGWJ9OIM130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561545.RAOfrHxfbuny3HTSWQxOlfKvmyt223zdKr2MWZGWJ9OIM130_provenance.
- assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP567454.RA8rHcA30zXZsE0WKxqWBNB-Polpvqv3hapkVmsJnQ5Y0130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567454.RA8rHcA30zXZsE0WKxqWBNB-Polpvqv3hapkVmsJnQ5Y0130_provenance.
- NP567962.RAw8yv4nlaUyFknMb3OyODxezSTz6h05xcH3rMcQvrizo130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567962.RAw8yv4nlaUyFknMb3OyODxezSTz6h05xcH3rMcQvrizo130_provenance.
- NP548283.RAMjyfqXhucFcRRdWUZUjRG6ju4vbSLeQhyS3YvI02qts130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548283.RAMjyfqXhucFcRRdWUZUjRG6ju4vbSLeQhyS3YvI02qts130_provenance.
- NP548284.RA82nJuu7ShG0zf-TV6jsXZfB_N7riXNgkobGuDSDK840130_assertion description "[The APL disease was characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver with an increased proportion of immature myeloperoxidase-expressing myeloid forms; transplantability to secondary recipients; and lack of cytogenetic abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548284.RA82nJuu7ShG0zf-TV6jsXZfB_N7riXNgkobGuDSDK840130_provenance.